Tag: China’s CAR T-Cell Trials

Home / China’s CAR T-Cell Trials

Categories

Strategies to optimize chimeric antigen receptor T-cell therapy in hematologic malignancies: Experience from China

 CAR T Cell therapyChimeric Antigen Receptor (CAR) T-cell therapy has changed the course of treatment for numerous hematologic malignancies like leukemia, lymphoma, and multiple myeloma. China is at ...
chinas-car-t-cell-trials

Scan the code